Saturn V Capital Management LP: 13F holdings
CIK 19644372026Q2
| Positions | 23 |
|---|
| Reported value | $697.5m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 23 (+2 vs prior quarter) |
|---|
| Reported value | $697.5m (+26.3%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| AMLX AMYLYX PHARMACEUTICALS INC | 4,624,101 | $83.0m | 11.9% |
| ALMS ALUMIS INC | 2,915,443 | $82.0m | 11.8% |
| ABVX ABIVAX SA | 518,865 | $69.1m | 9.9% |
| PCVX VAXCYTE INC | 852,914 | $49.6m | 7.1% |
| IMMIX BIOPHARMA INC | 4,658,429 | $48.0m | 6.9% |
| PHARVARIS N V | 1,314,122 | $45.4m | 6.5% |
| JAZZ PHARMACEUTICALS PLC | 160,938 | $38.8m | 5.6% |
| CELC CELCUITY INC | 370,318 | $38.7m | 5.6% |
| IRON DISC MEDICINE INC | 524,730 | $38.4m | 5.5% |
| CANDEL THERAPEUTICS INC | 3,303,686 | $34.0m | 4.9% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1964437")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples